From Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M:

Exosome Diagnostics Logo—

Cambridge, MA-based Exosome Diagnostics is developing fluid-based tests for cancer.

Underwriters and Partners

Xconomy Insight

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

From Our Editors · Special Report
Xcelerating Life Sciences San Francisco: Special Report
The AI, Big Data, and R&D Boom

Sponsored · Webinar
Oct. 28 – Accelerating COVID-19 Drug Discovery: Qualified Assays for Proinflammatory Cytokines
How Functional Cell-based Assays Support Clinical Programs Managing Proinflammatory Cytokines Associated with High Mortality
Eurofins DiscoverX

Xconomy on Demand

We offer a number of ways to subscribe for free!